Literature DB >> 18795089

Tissue and plasma concentrations of antibiotic during cardiac surgery with cardiopulmonary bypass--microdialysis study.

Marek Pojar1, Jiri Mandak, Jana Malakova, Iveta Jokesova.   

Abstract

AIM: Surgical-site infections are very serious complications of cardiac operations. Use of cardiopulmonary bypass (CPB) is associated with profound physiological changes, which affects the pharmacokinetic behaviour of prophylactic antibiotics. The aim of this study was to monitor tissue concentrations of cefuroxime in peripheral tissue (skeletal muscle) during cardiac surgery using CPB by means of a microdialysis.
METHODS: Eleven adult patients operated on using CPB were included in the study. Cefuroxime was the prophylactic antibiotic and study drug given. Microdialysis was performed by probe CMA 60 inserted into the patient's left deltoid muscle. Samples of dialysates were collected at intervals: before CPB, each 30 minutes of CPB and at the end of CPB. Samples of blood were collected at intervals: incision, start of CPB, each 30 minutes of CPB, at the end of CPB and at the end of surgery.
RESULTS: The mean (+/- S.D.) concentrations of cefuroxime in peripheral tissue were 105.4+/-41.1, 81.7+/-32.8, 74.6+/-26.0, 70.4+/-34.7, 60.5+/-27.2, 138.0+/-42.6 (mg l(-1)). Total plasma concentrations of cefuroxime were 154.4+/-41.6, 73.3+/-20.7, 67.1+/-20.4, 59.2+/-21.0, 49.0+/-16.4, 110.9+/-33.6 (mg l(-1)) and concentrations of free plasma fraction were 110.7+/-37.1, 62.2+/-18.8, 58.9+/-18.6, 48.4+/-16.6, 41.7+/-15.6, 97.6+/-28.6 (mg l(-1)). The plasma and tissue concentrations exceed throughout the operation time the minimum inhibitory concentration for most common suspected pathogens in cardiac surgery.
CONCLUSIONS: Results show that CPB can modify the time course of cefuroxime tissue and plasma concentrations. Microdialysis is suitable for antibiotic tissue measurement in cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18795089     DOI: 10.5507/bp.2008.022

Source DB:  PubMed          Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub        ISSN: 1213-8118            Impact factor:   1.245


  7 in total

1.  Cloxacillin concentrations in serum, subcutaneous fat, and muscle in patients with chronic critical limb ischemia.

Authors:  T B Jonsson; T K Nilsson; L H Breimer; J Schneede; B Arfvidsson; L Norgren
Journal:  Eur J Clin Pharmacol       Date:  2014-05-27       Impact factor: 2.953

2.  Blood concentrations of cefuroxime in cardiopulmonary bypass surgery.

Authors:  Daphne Bertholee; Peter G J ter Horst; Michel L Hijmering; Alexander J Spanjersberg; Wobbe Hospes; Bob Wilffert
Journal:  Int J Clin Pharm       Date:  2013-06-21

3.  Population Pharmacokinetic Model-Based Evaluation of Standard Dosing Regimens for Cefuroxime Used in Coronary Artery Bypass Graft Surgery with Cardiopulmonary Bypass.

Authors:  Saeed A Alqahtani; Abdullah S Alsultan; Hussain M Alqattan; Ahmed Eldemerdash; Turki B Albacker
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

Review 4.  Are children undergoing cardiac surgery receiving antibiotics at subtherapeutic levels?

Authors:  Jennifer H Huang; Rachel Sunstrom; Myrna Y Munar; Ganesh Cherala; Arthur Legg; Ali J Olyeai; Stephen M Langley
Journal:  J Thorac Cardiovasc Surg       Date:  2014-01-15       Impact factor: 5.209

5.  Pharmacokinetic Model for Cefuroxime Dosing during Cardiac Surgery under Cardiopulmonary Bypass.

Authors:  J Lanoiselée; P J Zufferey; S Hodin; N Tamisier; L Gergelé; J C Palao; S Campisi; S Molliex; J Morel; X Delavenne; E Ollier
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

6.  Targeting cefuroxime plasma concentrations during coronary artery bypass graft surgery with cardiopulmonary bypass.

Authors:  Marieke Aalbers; Peter G J ter Horst; Wobbe Hospes; Michel L Hijmering; Alexander J Spanjersberg
Journal:  Int J Clin Pharm       Date:  2015-03-20

7.  Cefuroxime plasma and tissue concentrations in patients undergoing elective cardiac surgery: Continuous vs bolus application. A pilot study.

Authors:  Keso Skhirtladze-Dworschak; Doris Hutschala; Georg Reining; Peter Dittrich; Anna Bartunek; Martin Dworschak; Edda M Tschernko
Journal:  Br J Clin Pharmacol       Date:  2019-02-13       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.